BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure.

Platini, F; Ortolan, E; Cavalieri, S; Massa, G; Filippini, DM; Alfieri, S; Bergamini, C; Resteghini, C; Orlandi, E; Paolini, B; Piazza, C; Perrone, F; Tamborini, E; Ferrarini, L; Serafini, MS; Cappelletti, V; Daidone, MG; Licitra, LF; Locati, LD

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):